CXCR6 and breast cancer: Phenotypic analysis of the markers we identified by scRNAseq revealed that expression of CXCR6, ICOS, JAML, NK1.1, NKG2D, and PD-1 by Vγ4+ and Vγ6+ cells remains unaffected by mammary tumor conditioning (Fig. 4 C).